Universe Pharmaceuticals (UPC) Equity Ratio (2021 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Equity Ratio for 5 consecutive years, with 0.81 as the latest value for Q3 2025.
- Quarterly Equity Ratio rose 20.95% to 0.81 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.81 through Sep 2025, up 20.95% year-over-year, with the annual reading at 0.81 for FY2025, 20.95% up from the prior year.
- Equity Ratio hit 0.81 in Q3 2025 for Universe Pharmaceuticals, up from 0.67 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 670.35 in Q3 2023 to a low of 0.67 in Q3 2024.
- Historically, Equity Ratio has averaged 253.18 across 5 years, with a median of 0.81 in 2025.
- Biggest five-year swings in Equity Ratio: surged 88474.92% in 2022 and later crashed 99.9% in 2024.
- Year by year, Equity Ratio stood at 0.67 in 2021, then soared by 88474.92% to 593.39 in 2022, then increased by 12.97% to 670.35 in 2023, then tumbled by 99.9% to 0.67 in 2024, then increased by 20.95% to 0.81 in 2025.
- Business Quant data shows Equity Ratio for UPC at 0.81 in Q3 2025, 0.67 in Q3 2024, and 670.35 in Q3 2023.